- Filed
- Nov 23, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 18, 2021 | 726.17M sh |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $2K |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $264 |
| Cash And Equivalents | Q3 2021 · Sep 30, 2020 | $96.38K |
| Cash And Equivalents | Q3 2021 · Dec 31, 2019 | $493.4K |
| Stockholders Equity | Q3 2021 · Sep 30, 2021 | −$12.68M |
| Stockholders Equity | Q3 2021 · Jun 30, 2021 | −$10.29M |
| Stockholders Equity | Q3 2021 · Mar 31, 2021 | −$11.85M |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | −$8.27M |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | −$11.05M |
| Stockholders Equity | Q3 2021 · Mar 31, 2020 | −$8.35M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | −$6.16M |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $13.48M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $17.4M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $13.58M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $17.51M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $137K |
| Current Assets | Q3 2021 · Dec 31, 2020 | $264 |
| Total Assets | Q3 2021 · Sep 30, 2021 | $902.4K |
| Total Assets | Q3 2021 · Dec 31, 2020 | $701.23K |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | $0.00 |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | $0.00 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | $0.00 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.01 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $0.00 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $0.00 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $0.00 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.01 |
| Net Income | Q3 2021 · Jun 30, 2021 | $798.96K |
| Net Income | Q3 2021 · Mar 31, 2021 | $3.72M |
| Net Income restated | Q3 2021 · Sep 30, 2020 | $2.68M |
| Net Income | Q3 2021 · Sep 30, 2020 | −$3.4M |
| Net Income | Q3 2021 · Jun 30, 2020 | −$3.79M |
| Net Income | Q3 2021 · Mar 31, 2020 | −$2.3M |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | −$1.53M |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $264.58K |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $799.96K |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | −$264.58K |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | −$799.96K |